UPC Case Law
Sumi Agro Limited and others v Syngenta Limited
Order of the UPC Court of Appeal of 19 December 2024, UPC CoA 523/2024
UPC Case Law by Pitch, edited by Bart Lieben · Published
TL;DR
The Court of Appeal excluded a further excerpt from a textbook that the appellant had already cited at first instance, because nothing had prevented it from filing those pages earlier. It admitted the respondent's new purchase and lab evidence on a possibly reformulated product, because the change of ingredient was disclosed only during the first-instance proceedings. Under R.222.2 RoP, a party that already had a source in hand will struggle to add more of it on appeal. Evidence prompted by the opponent's own late disclosures is likely to be admitted.
Key holding
Under R.222.2 RoP, a party that submitted pages from a publication at first instance has not justified that further pages from the same publication could not reasonably have been filed then, and the Court of Appeal may disregard them. Counter-evidence filed only on condition that the opponent's new evidence is admitted is disregarded once that evidence is excluded. Evidence on a possible new version of a contested product is admitted where the change of ingredient could not reasonably have been visible to the patentee and the party explains when and why it bought and analysed samples. Admission is decided on justification, relevance and the other party's position, without assessing the credibility of the evidence.
Questions decided
- Can further pages from a publication already filed at first instance be admitted on appeal under R.222.2 RoP?
- What happens to conditional counter-evidence when the evidence it answers is excluded?
- Is new evidence on a possibly reformulated contested product admissible on appeal?
- Does the Court of Appeal assess the credibility of new evidence when deciding whether to admit it?
Full summary
Read the full analyses for free — create a free account
With a free Academy account you read the full analysis of every Court of Appeal decision: the facts and procedure, the issues, the court’s reasoning and the practice points. Your name, an e-mail address and a password; no payment, and you can delete the account yourself at any time.
In the same case
- Decision · UPC CoA 10/2026
Sumi Agro Limited and others v Syngenta Limited (application by Gowling WLG)
The Court of Appeal held that a third party seeking access to written pleadings and evidence under R 262.1(b) RoP must apply to the instance where those documents were lodged: the Division for first-instance documents, the Court of Appeal for appeal documents.
- Decision · UPC CoA 523/2024
Sumi Agro Limited and others v Syngenta Limited
The Court of Appeal allowed Sumi to withdraw its application for rehearing.
- Decision · UPC CoA 523/2024
Sumi Agro Limited and others v Syngenta Limited
The Court of Appeal refused Docket Navigator, a patent litigation intelligence platform, access to the written pleadings and evidence in the Sumi Agro v Syngenta appeal, which it wanted in order to make them available to its subscribers.
- Order · UPC CoA 523/2024
Sumi Agro Limited and others v Syngenta Limited
The Court of Appeal upheld a provisional injunction for Syngenta against Sumi Agro's herbicide Kagura and extended it to Romania, which acceded to the UPC after the first-instance order.
- Order · UPC CoA 523/2024
Sumi Agro Limited and others v Syngenta Limited
A party that files a new document in a language other than the language of the proceedings for the first time before the UPC Court of Appeal must translate it unless the Court of Appeal relieves it of that duty.
More on procedure
- Decision · UPC CoA 163/2026
PAUSTIAN & PARTNER Patentanwälte mbB v NUC Electronics Europe GmbH and others
The Court of Appeal granted a patent law firm access to the statements of appeal and statements of grounds of appeal in three closed appeals concerning EP 2 028 981.
- Order · UPC CoA 133/2026
The Walt Disney Company and others v InterDigital VC Holdings, Inc.
A request under R 262A RoP to stop the other party from accessing or using confidential information cannot be made for the first time on appeal for material already filed at first instance.
- Decision · UPC CoA 49/2026
Guardant Health, Inc. v Sophia Genetics SA and others
The Court of Appeal set aside a EUR 600,000 award of representation costs because the successful party had backed it only with invoices reading "supply of legal services" and general assertions about complexity and urgency.